These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24948496)

  • 1. Incidental radiologic findings in the 22q11.2 deletion syndrome.
    Schmitt JE; Yi JJ; Roalf DR; Loevner LA; Ruparel K; Whinna D; Souders MC; McDonald-McGinn DM; Yodh E; Vandekar S; Zackai EH; Gur RC; Emanuel BS; Gur RE
    AJNR Am J Neuroradiol; 2014; 35(11):2186-91. PubMed ID: 24948496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities in brain white matter in adolescents with 22q11.2 deletion syndrome and psychotic symptoms.
    Kikinis Z; Cho KIK; Coman IL; Radoeva PD; Bouix S; Tang Y; Eckbo R; Makris N; Kwon JS; Kubicki M; Antshel KM; Fremont W; Shenton ME; Kates WR
    Brain Imaging Behav; 2017 Oct; 11(5):1353-1364. PubMed ID: 27730479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased incidence and size of cavum septum pellucidum in children with chromosome 22q11.2 deletion syndrome.
    Beaton EA; Qin Y; Nguyen V; Johnson J; Pinter JD; Simon TJ
    Psychiatry Res; 2010 Feb; 181(2):108-13. PubMed ID: 20074913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnitude and heterogeneity of brain structural abnormalities in 22q11.2 deletion syndrome: a meta-analysis.
    Rogdaki M; Gudbrandsen M; McCutcheon RA; Blackmore CE; Brugger S; Ecker C; Craig MC; Daly E; Murphy DGM; Howes O
    Mol Psychiatry; 2020 Aug; 25(8):1704-1717. PubMed ID: 31925327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis of 22q11.2 deletion syndrome in the context of newly developed psychosis].
    Kaltenboeck A; Friedrich F; Hinterbuchinger B; Litvan Z; Mossaheb N
    Neuropsychiatr; 2016 Dec; 30(4):223-226. PubMed ID: 27822729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.
    Schneider M; Debbané M; Bassett AS; Chow EW; Fung WL; van den Bree M; Owen M; Murphy KC; Niarchou M; Kates WR; Antshel KM; Fremont W; McDonald-McGinn DM; Gur RE; Zackai EH; Vorstman J; Duijff SN; Klaassen PW; Swillen A; Gothelf D; Green T; Weizman A; Van Amelsvoort T; Evers L; Boot E; Shashi V; Hooper SR; Bearden CE; Jalbrzikowski M; Armando M; Vicari S; Murphy DG; Ousley O; Campbell LE; Simon TJ; Eliez S;
    Am J Psychiatry; 2014 Jun; 171(6):627-39. PubMed ID: 24577245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between neurodevelopmental genes, neuroanatomy, and ultra high risk symptoms of psychosis in 22q11.2 deletion syndrome.
    Thompson CA; Karelis J; Middleton FA; Gentile K; Coman IL; Radoeva PD; Mehta R; Fremont WP; Antshel KM; Faraone SV; Kates WR
    Am J Med Genet B Neuropsychiatr Genet; 2017 Apr; 174(3):295-314. PubMed ID: 28139055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size.
    Sun D; Ching CRK; Lin A; Forsyth JK; Kushan L; Vajdi A; Jalbrzikowski M; Hansen L; Villalon-Reina JE; Qu X; Jonas RK; van Amelsvoort T; Bakker G; Kates WR; Antshel KM; Fremont W; Campbell LE; McCabe KL; Daly E; Gudbrandsen M; Murphy CM; Murphy D; Craig M; Vorstman J; Fiksinski A; Koops S; Ruparel K; Roalf DR; Gur RE; Schmitt JE; Simon TJ; Goodrich-Hunsaker NJ; Durdle CA; Bassett AS; Chow EWC; Butcher NJ; Vila-Rodriguez F; Doherty J; Cunningham A; van den Bree MBM; Linden DEJ; Moss H; Owen MJ; Murphy KC; McDonald-McGinn DM; Emanuel B; van Erp TGM; Turner JA; Thompson PM; Bearden CE
    Mol Psychiatry; 2020 Aug; 25(8):1822-1834. PubMed ID: 29895892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in understanding the relationship between 22q11.2 deletion syndrome and psychosis.
    O'Rourke L; Murphy KC
    Curr Opin Psychiatry; 2019 Mar; 32(2):67-72. PubMed ID: 30394904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter abnormalities in 22q11.2 deletion syndrome: preliminary associations with the Nogo-66 receptor gene and symptoms of psychosis.
    Perlstein MD; Chohan MR; Coman IL; Antshel KM; Fremont WP; Gnirke MH; Kikinis Z; Middleton FA; Radoeva PD; Shenton ME; Kates WR
    Schizophr Res; 2014 Jan; 152(1):117-23. PubMed ID: 24321711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
    Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
    Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychosis and movement disorders in an adolescent with 22q11.2 deletion syndrome].
    Zinkstok JR; Velders F; Rieken R; Houben M; Fiksinski A; van Amelsvoort TAMJ; Boot E
    Tijdschr Psychiatr; 2020; 62(3):229-233. PubMed ID: 32207133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome.
    Gothelf D; Feinstein C; Thompson T; Gu E; Penniman L; Van Stone E; Kwon H; Eliez S; Reiss AL
    Am J Psychiatry; 2007 Apr; 164(4):663-9. PubMed ID: 17403981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct white-matter aberrations in 22q11.2 deletion syndrome and patients at ultra-high risk for psychosis.
    Bakker G; Caan MW; Schluter RS; Bloemen OJ; da Silva-Alves F; de Koning MB; Boot E; Vingerhoets WA; Nieman DH; de Haan L; Booij J; van Amelsvoort TA
    Psychol Med; 2016 Aug; 46(11):2299-311. PubMed ID: 27193339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural substrates of psychosis revealed by altered dependencies between brain activity and white-matter architecture in individuals with 22q11 deletion syndrome.
    Bortolin K; Delavari F; Preti MG; Sandini C; Mancini V; Mullier E; Van De Ville D; Eliez S
    Neuroimage Clin; 2022; 35():103075. PubMed ID: 35717884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive profile in psychotic versus nonpsychotic individuals with 22q11.2 deletion syndrome.
    Weinberger R; Yi J; Calkins M; Guri Y; McDonald-McGinn DM; Emanuel BS; Zackai EH; Ruparel K; Carmel M; Michaelovsky E; Weizman A; Gur RC; Gur RE; Gothelf D
    Eur Neuropsychopharmacol; 2016 Oct; 26(10):1610-8. PubMed ID: 27524298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Education and employment trajectories from childhood to adulthood in individuals with 22q11.2 deletion syndrome.
    Mosheva M; Pouillard V; Fishman Y; Dubourg L; Sofrin-Frumer D; Serur Y; Weizman A; Eliez S; Gothelf D; Schneider M
    Eur Child Adolesc Psychiatry; 2019 Jan; 28(1):31-42. PubMed ID: 29934817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter abnormalities in 22q11.2 deletion syndrome patients showing cognitive decline.
    Nuninga JO; Bohlken MM; Koops S; Fiksinski AM; Mandl RCW; Breetvelt EJ; Duijff SN; Kahn RS; Sommer IEC; Vorstman JAS
    Psychol Med; 2018 Jul; 48(10):1655-1663. PubMed ID: 29143717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prodromal symptoms in adolescents with 22q11.2 deletion syndrome and schizotypal personality disorder.
    Shapiro DI; Cubells JF; Ousley OY; Rockers K; Walker EF
    Schizophr Res; 2011 Jun; 129(1):20-8. PubMed ID: 21507614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Event-related potential (ERP) markers of 22q11.2 deletion syndrome and associated psychosis.
    Francisco AA; Foxe JJ; Molholm S
    J Neurodev Disord; 2023 Jun; 15(1):19. PubMed ID: 37328766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.